Intech Biopharm Corporation announced earnings results for the full year ended December 31, 2018. For the full year, the company announced total revenue was TWD 17.234 million compared to TWD 16.608 million a year ago. Operating loss was TWD 230.952 million compared to TWD 246.748 million a year ago. Net loss was TWD 222.075 million compared to TWD 239.314 million a year ago. Basic loss per share was TWD 2.86 compared to TWD 3.42 a year ago.